Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 13, 2022
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
[ Wed, Apr 13th 2022
] - WOPRAI
Tue, April 12, 2022
[ Tue, Apr 12th 2022
] - WOPRAI
[ Tue, Apr 12th 2022
] - WOPRAI
[ Tue, Apr 12th 2022
] - WOPRAI
[ Tue, Apr 12th 2022
] - WOPRAI
[ Tue, Apr 12th 2022
] - WOPRAI
[ Tue, Apr 12th 2022
] - WOPRAI
Andrew Berens Maintained (ZNTL) at Buy with Decreased Target to $67 on, Apr 12th, 2022
Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $78 to $67 on, Apr 12th, 2022.
Andrew has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $74 on, Monday, April 11th, 2022
- Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $67 on, Wednesday, April 6th, 2022
